SCHEMBL17954609

SCHEMBL17954609

c1ccc2c(c1)Cc1ccc3sc4ccccc4c3c1-2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K9 P80192 2/20 0.46
MAP3K11 Q16584 2/20 0.46
MAPT P10636 4/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 1/20 0.43
DUSP3 P51452 1/20 0.43
BLM P54132 1/20 0.43
PTPN5 P54829 1/20 0.43
KMT2A Q03164 1/20 0.43
PTPN11 Q06124 1/20 0.43
MCL1 Q07820 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
GPR3 P46089 1/20 0.41
MAOA P21397 2/20 0.36
BRDT Q58F21 1/20 0.35
HPGD P15428 3/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16451426 0.87 MAPT (0.43) MAP3K9MAP3K11MAPTPOLBMEN1
SCHEMBL16437551 0.86 MAP3K9 (0.44) MAP3K9MAP3K11MAPTPOLBMEN1
SCHEMBL16437555 0.80 MAP3K9 (0.44) MAP3K9MAP3K11MAPTPOLBMEN1
SCHEMBL17431184 0.79 MAP3K9 (0.45) MAP3K9MAP3K11MAPTPOLBMEN1
Fluorene SCHEMBL17889181 0.79 GPR3 (0.61) MAP3K9MAP3K11MAPTPOLBTDP1
SCHEMBL18666286 0.78 MAPT (0.37) MAP3K9MAP3K11MAPTPOLBMEN1
SCHEMBL17953564 0.77 MAP3K9 (0.46) MAP3K9MAP3K11MAPTPOLBMEN1
SCHEMBL17953630 0.77 MAP3K9 (0.46) MAP3K9MAP3K11MAPTPOLBMEN1
SCHEMBL25456509 0.77 MAP3K9 (0.39) MAP3K9MAP3K11MAPTPOLBMEN1
SCHEMBL4848717 0.75 MAOA (0.43) MAP3K9MAP3K11MAPTPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160218300-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160218300-A1 Organic Electroluminescent Materials and Devices OCIAD2, OCIAD1, OSBP MAP3K9 2796/4885MAP3K11 3327/4885MAPT 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.